Andrew Farquharson - Net Worth and Insider Trading

Andrew Farquharson Net Worth

The estimated net worth of Andrew Farquharson is at least $69,924 dollars as of 2025-07-25. Andrew Farquharson is the Director of Rani Therapeutics Holdings Inc and owns about 139,458 shares of Rani Therapeutics Holdings Inc (RANI) stock worth over $69,924. Details can be seen in Andrew Farquharson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Farquharson has not made any transactions after 2022-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Andrew Farquharson

To

Andrew Farquharson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Farquharson owns 1 companies in total, including Rani Therapeutics Holdings Inc (RANI) .

Click here to see the complete history of Andrew Farquharson’s form 4 insider trades.

Insider Ownership Summary of Andrew Farquharson

Ticker Company Transaction Date Type of Owner
RANI Rani Therapeutics Holdings Inc 2022-08-17 director

Andrew Farquharson Latest Holdings Summary

Andrew Farquharson currently owns a total of 1 stock. Andrew Farquharson owns 139,458 shares of Rani Therapeutics Holdings Inc (RANI) as of August 17, 2022, with a value of $69,924.

Latest Holdings of Andrew Farquharson

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RANI Rani Therapeutics Holdings Inc 2022-08-17 139,458 0.50 69,924

Holding Weightings of Andrew Farquharson


Andrew Farquharson Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Farquharson has made a total of 1 transactions in Rani Therapeutics Holdings Inc (RANI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Rani Therapeutics Holdings Inc is the sale of 80,252 shares on August 17, 2022, which brought Andrew Farquharson around $853,881.

Insider Trading History of Andrew Farquharson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Farquharson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Farquharson Ownership Network

Ownership Network List of Andrew Farquharson

No Data

Ownership Network Relation of Andrew Farquharson

Insider Network Chart


Andrew Farquharson Owned Company Details

What does Rani Therapeutics Holdings Inc do?

Who are the key executives at Rani Therapeutics Holdings Inc?

Andrew Farquharson is the director of Rani Therapeutics Holdings Inc. Other key executives at Rani Therapeutics Holdings Inc include CHIEF BUSINESS OFFICER Kate Mckinley , director & CEO Talat Imran , and 10 percent owner South Cone Investments Limited Partnership .

Rani Therapeutics Holdings Inc (RANI) Insider Trades Summary

Over the past 18 months, Andrew Farquharson made no insider transaction in Rani Therapeutics Holdings Inc (RANI). Other recent insider transactions involving Rani Therapeutics Holdings Inc (RANI) include a net sale of 3,829,360 shares made by South Cone Investments Limited Partnership , a net purchase of 17,960 shares made by Kate Mckinley , and a net purchase of 10,296 shares made by Talat Imran .

In summary, during the past 3 months, insiders sold 0 shares of Rani Therapeutics Holdings Inc (RANI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,829,360 shares of Rani Therapeutics Holdings Inc (RANI) were sold and 28,256 shares were bought by its insiders, resulting in a net sale of 3,801,104 shares.

Rani Therapeutics Holdings Inc (RANI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rani Therapeutics Holdings Inc Insider Transactions

No Available Data

Andrew Farquharson Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Farquharson. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrew Farquharson's mailing address is: San Jose Ca 95131.